These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282 [TBL] [Abstract][Full Text] [Related]
3. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset. van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933 [TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment in Alzheimer's disease is modified by APOE genotype. van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691 [TBL] [Abstract][Full Text] [Related]
11. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Berry-Kravis E; Bennett DA Neurocase; 2005 Feb; 11(1):3-7. PubMed ID: 15804918 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. Hsiung GY; Sadovnick AD; Feldman H CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624 [TBL] [Abstract][Full Text] [Related]
13. Repetitive negative thinking as a predictor of depression and anxiety: A longitudinal cohort study. Spinhoven P; van Hemert AM; Penninx BW J Affect Disord; 2018 Dec; 241():216-225. PubMed ID: 30138805 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease. Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010 [TBL] [Abstract][Full Text] [Related]
16. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. Sager MA; Hermann B; La Rue A J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer's patients--an open-label trial. Kennelly S; Abdullah L; Kenny RA; Mathura V; Luis CA; Mouzon B; Crawford F; Mullan M; Lawlor B Int J Geriatr Psychiatry; 2012 Apr; 27(4):415-22. PubMed ID: 21560164 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease. Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669 [TBL] [Abstract][Full Text] [Related]
19. APOE ε4: the most prevalent yet understudied risk factor for Alzheimer's disease. Michaelson DM Alzheimers Dement; 2014 Nov; 10(6):861-8. PubMed ID: 25217293 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos. Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]